Valerio Therapeutics S.A.

ALVIO.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-€0-€13-€11-€9
Dep. & Amort.€0€2€2€0
Deferred Tax€0€0€0€0
Stock-Based Comp.€0€0€0€0
Change in WC-€4-€6€2-€3
Other Non-Cash€0€12€0€1
Operating Cash Flow-€4-€6-€7-€9
Investing Activities
PP&E Inv.-€0-€0-€0-€0
Net Acquisitions€0-€0€0€0
Inv. Purchases€0€0€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.€0-€1€0€0
Investing Cash Flow€0-€1-€0-€0
Financing Activities
Debt Repay.€5-€5€4-€1
Stock Issued€0€6€0€0
Stock Repurch.€0€0€0-€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€0-€0-€0-€0
Financing Cash Flow€5€0€4-€1
Forex Effect-€0€4-€0€0
Net Chg. in Cash€1-€3-€3-€10
Supplemental Information
Beg. Cash€1€4€7€17
End Cash€3€1€4€7
Free Cash Flow-€4-€6-€7-€10
Valerio Therapeutics S.A. (ALVIO.PA) Financial Statements & Key Stats | AlphaPilot